TG Therapeutics TGTX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's total current assets?
- TG Therapeutics (TGTX) reported total current assets of $1.09B in Q1 2026.
- How has TG Therapeutics's total current assets changed year-over-year?
- TG Therapeutics's total current assets increased by 68.7% year-over-year, from $644.51M to $1.09B.
- What is the long-term trend for TG Therapeutics's total current assets?
- Over 5 years (2020 to 2025), TG Therapeutics's total current assets has grown at a 0.6% compound annual growth rate (CAGR), from $611.74M to $630.76M.
- What does total current assets mean?
- The sum of all assets the company expects to turn into cash or use up within one year.
- How do you interpret total current assets?
- Higher levels indicate stronger short-term liquidity and a greater ability to meet immediate financial obligations.
- How does total current assets compare across companies?
- Essential for assessing the working capital position relative to industry peers.